Heart Surgery Drug Trasylol Withdrawn from Market

The German pharmaceutical company, Bayer AG, announced that it will withdraw Trasylol, its controversial drug used for heart surgery, from the market. The withdrawal was due in part to a study performed in Canada which suggested that Trasylol increased rates of death.

The New England Journal of Medicine published the results of a study it conducted finding that Trasylol increased the risks of stroke, heart attack, kidney failure, and death. The research concluded that stopping the use of Trasylol would result in the prevention of 10,000 to 11,000 cases of kidney failure per year along with the savings of over … Read the rest